Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Boehringer Ingelheim
Express Scripts
AstraZeneca
Merck

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Litigation Details for TEVA WOMEN'S HEALTH, INC. v. LUPIN, LTD. (D.N.J. 2010)

See Plans and Pricing

« Back to Dashboard

TEVA WOMEN'S HEALTH, INC. v. LUPIN, LTD. (D.N.J. 2010)

Docket   Start Trial Date Filed 2010-02-03
Court District Court, D. New Jersey Date Terminated 2012-06-29
Cause 35:271 Patent Infringement Assigned To Peter G. Sheridan
Jury Demand None Referred To Magistrate Judge Douglas E. Ar
Parties FAMY CARE LTD.; LUPIN PHARMACEUTICALS, INC.; LUPIN, LTD.; MYLAN INC.; MYLAN PHARMACEUTICALS INC.; TEVA WOMEN'S HEALTH, INC.
Patents 4,962,098; 4,971,998; 5,108,995; 5,208,225; 5,382,573; 5,552,394; 5,898,032; 6,500,814; 6,787,531; 7,320,969; RE35,724; RE36,247; RE37,838
Attorneys ARNOLD B. CALMANN; GERI L. ALBIN; KAREN A. CONFOY; MICHAEL E. PATUNAS; MICHAEL LLOYD BINNS
Firms McGuire Woods LLP
Link to Docket External link to docket
Small Molecule Drugs cited in TEVA WOMEN'S HEALTH, INC. v. LUPIN, LTD.

Details for TEVA WOMEN'S HEALTH, INC. v. LUPIN, LTD. (D.N.J. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-02-03 1 Bond.i et al. 4,762,717 A 8/1988 Crowley, Jr. 4,962,098 A 10/1990 Boissonneault 4,971,998 A 11/ 1990 Wurtman…of that patent. A copy of the ‘969 Patent is attached hereto as Exhibit A. 10. The ‘969 Patent is directed…. This is a civil action for patent infringement arising under the Patent Laws of the United States, …United States Patent and Trademark Office (“USPTO”) duly and legally issued U.S. Patent No. 7,320,969 …its belief that the ‘969 Patent is invalid or that the claims of the ‘969 Patent will not be infringed by External link to document
2011-12-16 122 for Summary Judgment of Invalidity of the 7,320,969 Patent for Obviousness by LUPIN PHARMACEUTICALS, … for Summary Judgment of Invalidity of the 7,320,969 Patent for Obviousness (Public-Redacted), # 3 Proposed…2010 29 June 2012 3:10-cv-00603 830 Patent None District Court, D. New Jersey External link to document
2011-12-16 123 for Summary Judgment of Invalidity of the 7,320,969 Patent for Obviousness filed by LUPIN PHARMACEUTICALS… for Summary Judgment of Invalidity of the 7,320,969 Patent for Obviousness (Sealed))(CONFOY, KAREN) (…2010 29 June 2012 3:10-cv-00603 830 Patent None District Court, D. New Jersey External link to document
2011-12-16 124 for Summary Judgment of Invalidity of the 7,320,969 Patent for Obviousness re 122 MOTION for Summary …Summary Judgment of Invalidity of the 7,320,969 Patent for Obviousness by LUPIN PHARMACEUTICALS, INC., LUPIN…2010 29 June 2012 3:10-cv-00603 830 Patent None District Court, D. New Jersey External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
AstraZeneca
Dow
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.